Force Factor Expands GLP-1 Supplement Category With Eriomin-Backed Product Line

A new product launch from Force Factor and Ingredients by Nature reflects ongoing activity in the market for supplements targeting glucagon-like peptide-1 (GLP-1) pathways.¹

This collaboration introduces three products under the Super GLP-1 Support line, each formulated with the citrus bioflavonoid complex Eriomin. The products are scheduled to roll out nationwide at Walmart and CVS locations this spring.

The lineup includes Super GLP-1 Support Soft Chews, Super GLP-1 Extra Strength Capsules, and Super GLP-1 Support + Akkermansia Capsules, targeting metabolic health, weight management, and glucose balance through what the companies describe as natural GLP-1 activation.

What Is Driving Interest in GLP-1–Supporting Supplements?

GLP-1, a hormone involved in satiety and glucose regulation, has become a focal point in both pharmaceutical and nutritional product development. While widely associated with prescription medications, the hormone itself is naturally produced in the body, prompting supplement companies to explore ingredients that may support its endogenous activity.

The inclusion of Eriomin reflects this shift. Derived from lemons, the ingredient has been studied for its potential effects on blood glucose metabolism, inflammation, and cardiometabolic health. It is supported by multiple patents and clinical studies.²

Interest in metabolic health ingredients has been rising alongside consumer demand for alternatives to pharmaceutical interventions. Over the past few years, there has been increasing innovation in blood sugar management and weight support categories, particularly as brands emphasize clinically substantiated, naturally derived compounds.

What Differentiates Eriomin in the Ingredient Landscape?

Company executives highlighted Eriomin’s clinical backing and intellectual property as key differentiators in a crowded category, including Rob Brewster, president of Ingredients by Nature, who noted that, “Eriomin’s ability to naturally activate GLP-1 pathways makes it an ideal fit for today’s consumer seeking effective and evidence-based metabolic support.”

The emphasis on clinical validation aligns with broader industry trends toward substantiation and transparency, two areas that have gained importance among both regulators and consumers.

How Are Brands Positioning Metabolic Formulas?

The new product line also reflects evolving formulation strategies that combine established bioactives with emerging ingredients. One of the three products includes Akkermansia muciniphila, a probiotic associated with metabolic and gut health research.

According to Daniel Wallace, CEO and co-founder of Force Factor, ingredient synergy played a central role in product development. “We selected Eriomin for its impressive clinical validation and its synergistic potential when paired with other bioactives,” he said. “Our new Super GLP-1 Support line represents a major step forward in natural metabolic support.”

The availability of multiple formats, including soft chews and capsules, suggests a focus on consumer convenience and personalization, trends that continue to shape product development across the supplement industry.

What Does This Launch Indicate About Retail and Consumer Demand?

The nationwide placement of the Super GLP-1 Support line at major retailers points to increasing mainstream demand for metabolic health solutions. Retail expansion into chains like Walmart and CVS indicates confidence in the category’s commercial viability and consumer awareness.

The partnership between Force Factor and Ingredients by Nature underscores a shared emphasis on ingredient sourcing, transparency, and science-backed positioning. As consumer interest in weight management and glucose support continues to grow, launches such as this highlight how supplement brands are leveraging clinically studied ingredients to differentiate in an increasingly competitive market.

References

1. Force Factor launches Super GLP-1 Support line at Walmart featuring Eriomin from Ingredients by Nature. April 28, 2026. Accessed April 29, 2026. Press release provided via email.

2. Ramos FMM, Ribeiro CB, Cesar TB, et al. Lemon flavonoids nutraceutical (Eriomin) attenuates prediabetes intestinal dysbiosis: a double-blind randomized controlled trial. Food Sci Nutr. 2023;11(11):7283-7295. doi:10.1002/fsn3.3654.